Literature DB >> 8235180

Estimating the causal effect of smoking cessation in the presence of confounding factors using a rank preserving structural failure time model.

S D Mark1, J M Robins.   

Abstract

Estimating the causal effect of quitting smoking on time to death or first myocardial infarction requires that one control for the differences in risk factors between individuals who elect to quite at each time t versus those who elect to continue smoking at time t. In this paper we examine the limitations of standard time varying Cox proportional hazards models to yield tests and estimates of this effect. Implementing the method of G-estimation proposed by Robins, we perform an observational analysis of data from the Multiple Risk Factor Intervention Trial (MRFIT) and estimate the causal effect of cigarette cessation while controlling for such time varying confounders as angina. We reject the null hypothesis of no effect of quitting on time to failure, and estimate that by quitting smoking, an individual increases by 50 per cent his time to death or first myocardial infarction (MI).

Entities:  

Mesh:

Year:  1993        PMID: 8235180     DOI: 10.1002/sim.4780121707

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  10 in total

1.  Semiparametric transformation models for causal inference in time to event studies with all-or-nothing compliance.

Authors:  Wen Yu; Kani Chen; Michael E Sobel; Zhiliang Ying
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2015-03-01       Impact factor: 4.488

2.  Causal inference in occupational epidemiology: accounting for the healthy worker effect by using structural nested models.

Authors:  Ashley I Naimi; David B Richardson; Stephen R Cole
Journal:  Am J Epidemiol       Date:  2013-09-27       Impact factor: 4.897

3.  Estimating absolute risks in the presence of nonadherence: an application to a follow-up study with baseline randomization.

Authors:  Sengwee Toh; Sonia Hernández-Díaz; Roger Logan; James M Robins; Miguel A Hernán
Journal:  Epidemiology       Date:  2010-07       Impact factor: 4.822

4.  MIMICKING COUNTERFACTUAL OUTCOMES TO ESTIMATE CAUSAL EFFECTS.

Authors:  Judith J Lok
Journal:  Ann Stat       Date:  2017-05-16       Impact factor: 4.028

5.  Weighted estimators of the complier average causal effect on restricted mean survival time with observed instrument-outcome confounders.

Authors:  Sai H Dharmarajan; Yun Li; Douglas Lehmann; Douglas E Schaubel
Journal:  Biom J       Date:  2020-12-21       Impact factor: 2.207

6.  A comparison of methods to estimate the hazard ratio under conditions of time-varying confounding and nonpositivity.

Authors:  Ashley I Naimi; Stephen R Cole; Daniel J Westreich; David B Richardson
Journal:  Epidemiology       Date:  2011-09       Impact factor: 4.822

7.  Estimating the effect of cumulative occupational asbestos exposure on time to lung cancer mortality: using structural nested failure-time models to account for healthy-worker survivor bias.

Authors:  Ashley I Naimi; Stephen R Cole; Michael G Hudgens; David B Richardson
Journal:  Epidemiology       Date:  2014-03       Impact factor: 4.822

8.  Long-term impact of secondary preventive treatments in patients with stable angina.

Authors:  Zoltán Vokó; Sophie de Brouwer; Jacobus Lubsen; Nicolas Danchin; Jan-Erik Otterstad; Peter H J M Dunselman; Bridget-Anne Kirwan
Journal:  Eur J Epidemiol       Date:  2011-02-19       Impact factor: 8.082

9.  Estimating the causal effect of conduct disorder on the time from first substance use to substance use disorders using g-estimation.

Authors:  Minje Sung; Al Erkanli; E Jane Costello
Journal:  Subst Abus       Date:  2014       Impact factor: 3.716

10.  Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation.

Authors:  David M Vock; Michael T Durheim; Wayne M Tsuang; C Ashley Finlen Copeland; Anastasios A Tsiatis; Marie Davidian; Megan L Neely; David J Lederer; Scott M Palmer
Journal:  Ann Am Thorac Soc       Date:  2017-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.